For the quarter ending 2026-03-31, OMDA had -$132,506K decrease in cash & cash equivalents over the period. -$7,662K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | 14,967 | -3,178 | -14,759 |
| Depreciation and amortization | -2,536 | 1,359 | 2,685 |
| Share-based compensation | -5,001 | 3,536 | 5,674 |
| Loss on debt extinguishment | - | -2,109 | - |
| Loss on disposal of property and equipment | 0 | 0 | -2 |
| Amortization of debt issuance costs | -285 | 33 | 252 |
| Non-cash operating lease expense | -447 | 65 | 382 |
| Change in fair value of warrant liabilities | -1,468 | 212 | 1,256 |
| Provision for credit losses | -679 | 995 | 490 |
| Amortization of deferred commissions | -1,509 | 906 | 1,561 |
| Accounts receivable | -13,308 | 9,154 | 10,360 |
| Inventory | -507 | -321 | 173 |
| Prepaid expenses and other current assets | -31 | 700 | 870 |
| Deferred commissions | -117 | 896 | 1,423 |
| Other non-current assets | 242 | -63 | -118 |
| Accounts payable | -3,497 | 357 | 1,016 |
| Operating lease liabilities | 415 | 0 | -415 |
| Accrued expenses and other current liabilities | -16,947 | 12,562 | -4,780 |
| Deferred revenue | -3,332 | 1,632 | 5,995 |
| Other non-current liabilities | 0 | -89 | 89 |
| Net cash used in operating activities | -8,707 | 10,133 | -13,260 |
| Purchases of property and equipment | -1,045 | 537 | 586 |
| Capitalized internal-use software costs | -1,884 | 1,450 | 1,913 |
| Net cash used in investing activities | 2,929 | -1,987 | -2,499 |
| Repayment of debt principal | - | 30,963 | - |
| Proceeds from exercise of stock options | -2,746 | 2,085 | 3,908 |
| Payment of debt extinguishment costs | - | 1,430 | - |
| Proceeds from initial public offering, net of underwriting discounts and commissions | - | 0 | 160,532 |
| Taxes paid related to net share settlement of equity awards | 127 | - | - |
| Payment of deferred offering costs | -4,284 | 2,357 | 1,927 |
| Net cash provided by financing activities | -126,728 | -32,665 | 162,513 |
| Net decrease in cash and cash equivalents | -132,506 | -24,519 | 146,754 |
| Cash and cash equivalents at beginning of period | 198,627 | 76,392 | - |
| Cash and cash equivalents at end of period | 211,765 | 198,627 | - |
Omada Health, Inc. (OMDA)
Omada Health, Inc. (OMDA)